Özlem Topaloglu

3.0k total citations · 2 hit papers
22 papers, 2.4k citations indexed

About

Özlem Topaloglu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Özlem Topaloglu has authored 22 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Oncology. Recurrent topics in Özlem Topaloglu's work include Hematopoietic Stem Cell Transplantation (4 papers), Acute Myeloid Leukemia Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Özlem Topaloglu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Acute Myeloid Leukemia Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Özlem Topaloglu collaborates with scholars based in United States, Germany and South Korea. Özlem Topaloglu's co-authors include Paula M Geigle, Roberta W. Scherer, Shiraz I. Mishra, Debra R. Berlanstein, Claire Snyder, Carolyn Gotay, David Sidransky, Mohammad Obaidul Hoque, Shahnaz Begum and Eli Rosenbaum and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Özlem Topaloglu

22 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exercise interventions on health-related quality of life for cancer survivors

2012 628 citations Shiraz I. Mishra, Roberta W. Scherer et al. Cochrane Database of Systematic Reviews profile →
Exercise interventions on health-related quality of life for people with cancer during active treatment

2012 531 citations Shiraz I. Mishra, Roberta W. Scherer et al. Cochrane Database of Systematic Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Özlem Topaloglu United States	14	1.3k	742	604	513	312	22	2.4k
Frank D. Gilliland United States	12	1.6k 1.2×	361 0.5×	397 0.7×	354 0.7×	538 1.7×	14	2.4k
Mark S. Walker United States	26	855 0.7×	462 0.6×	162 0.3×	572 1.1×	231 0.7×	121	2.1k
April Coan United States	26	1.3k 1.0×	434 0.6×	314 0.5×	655 1.3×	146 0.5×	38	3.0k
Jakob Eberhard Sweden	35	920 0.7×	855 1.2×	238 0.4×	370 0.7×	103 0.3×	128	3.2k
Thomas Cerny Switzerland	25	921 0.7×	568 0.8×	131 0.2×	477 0.9×	229 0.7×	53	2.2k
Steven Gallinger Canada	24	874 0.7×	1.2k 1.7×	223 0.4×	587 1.1×	129 0.4×	68	2.8k
Whitfield B. Growdon United States	31	616 0.5×	545 0.7×	300 0.5×	233 0.5×	202 0.6×	139	2.7k
Frederick D. Grant United States	25	604 0.5×	459 0.6×	221 0.4×	428 0.8×	220 0.7×	72	2.6k
Cora M. Aalfs Netherlands	24	658 0.5×	473 0.6×	263 0.4×	161 0.3×	254 0.8×	81	1.9k
Adda Grimberg United States	28	342 0.3×	1.1k 1.5×	550 0.9×	232 0.5×	220 0.7×	85	3.0k

Countries citing papers authored by Özlem Topaloglu

Since Specialization

Citations

This map shows the geographic impact of Özlem Topaloglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özlem Topaloglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özlem Topaloglu more than expected).

Fields of papers citing papers by Özlem Topaloglu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özlem Topaloglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özlem Topaloglu. The network helps show where Özlem Topaloglu may publish in the future.

Co-authorship network of co-authors of Özlem Topaloglu

This figure shows the co-authorship network connecting the top 25 collaborators of Özlem Topaloglu. A scholar is included among the top collaborators of Özlem Topaloglu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özlem Topaloglu. Özlem Topaloglu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corbacioglu, Selim, Özlem Topaloglu, & S. Aggarwal. (2022). A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Clinical Drug Investigation. 42(6). 465–476. 10 indexed citations

Ungaro, Ryan C., et al.. (2020). Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics. 51(9). 831–842. 71 indexed citations

Corbacioglu, Selim, et al.. (2020). A Systematic Review of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Biology of Blood and Marrow Transplantation. 26(3). S133–S133. 2 indexed citations

Aggarwal, S., et al.. (2020). A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting. Clinical and Applied Thrombosis/Hemostasis. 26. 2874333730–2874333730. 2 indexed citations

Richardson, Paul G., S. Aggarwal, Özlem Topaloglu, Kathleen F. Villa, & Selim Corbacioglu. (2019). Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS). Bone Marrow Transplantation. 54(12). 1951–1962. 43 indexed citations

Lee, Juna, Piotr Wysocki, Özlem Topaloglu, et al.. (2015). Epigenetic silencing of S100A2 in bladder and head and neck cancers. Oncoscience. 2(4). 410–418. 8 indexed citations

Mishra, Shiraz I., Roberta W. Scherer, Claire Snyder, et al.. (2012). Exercise interventions on health‐related quality of life for people with cancer during active treatment. Clinical Otolaryngology. 37(5). 390–392. 164 indexed citations

Mishra, Shiraz I., Roberta W. Scherer, Paula M Geigle, et al.. (2012). Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database of Systematic Reviews. CD007566–CD007566. 628 indexed citations breakdown →

Horowitz, David P., Özlem Topaloglu, Yonggang Zhang, & Fred Bunz. (2008). Deficiency of Bloom syndrome helicase activity is radiomimetic. Cancer Biology & Therapy. 7(11). 1783–1786. 3 indexed citations

10.

Aggarwal, Saurabh, W. Nathaniel Brennen, Thomas P. Kole, et al.. (2007). Fibroblast Activation Protein Peptide Substrates Identified from Human Collagen I Derived Gelatin Cleavage Sites. Biochemistry. 47(3). 1076–1086. 80 indexed citations

11.

Hoque, Mohammad Obaidul, Shahnaz Begum, Özlem Topaloglu, et al.. (2006). Quantitation of Promoter Methylation of Multiple Genes in Urine DNA and Bladder Cancer Detection. JNCI Journal of the National Cancer Institute. 98(14). 996–1004. 212 indexed citations

12.

Topaloglu, Özlem, Andreas Meinhardt, Arvind Dev, et al.. (2006). Premature translation of transition protein 2 mRNA causes sperm abnormalities and male infertility. Molecular Reproduction and Development. 74(3). 273–279. 47 indexed citations

13.

Aggarwal, Saurabh, Pratap Singh, Özlem Topaloglu, John T. Isaacs, & Samuel R. Denmeade. (2006). A Dimeric Peptide That Binds Selectively to Prostate-Specific Membrane Antigen and Inhibits its Enzymatic Activity. Cancer Research. 66(18). 9171–9177. 84 indexed citations

14.

Topaloglu, Özlem. (2005). Improved methods for the generation of human gene knockout and knockin cell lines. Nucleic Acids Research. 33(18). e158–e158. 60 indexed citations

15.

Hoque, Mohammad Obaidul, Özlem Topaloglu, Shahnaz Begum, et al.. (2005). Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects. Journal of Clinical Oncology. 23(27). 6569–6575. 190 indexed citations

16.

Fomenkov, Alexey, Yi‐Ping Huang, Özlem Topaloglu, et al.. (2003). p63α Mutations Lead to Aberrant Splicing of Keratinocyte Growth Factor Receptor in the Hay-Wells Syndrome. Journal of Biological Chemistry. 278(26). 23906–23914. 78 indexed citations

17.

Onay, Tuncer, Julian Zielenski, Özlem Topaloglu, et al.. (2001). Cystic Fibrosis Mutations and Associated Haplotypes in TurkishCystic Fibrosis Patients. Human Biology. 73(2). 3. 3 indexed citations

18.

Onay, Tuncer, Julian Zielenski, Özlem Topaloglu, et al.. (2001). Cystic Fibrosis Mutation and Associated Haplotypes in Turkish Cystic Fibrosis Patients. Human Biology. 73(2). 191–203. 19 indexed citations

19.

Topaloglu, Özlem, Gregor Schlüter, Karim Nayernia, & Wolfgang Engel. (2001). A 74-bp Promoter of the Tnp2 Gene Confers Testis- and Spermatid-Specific Expression in Transgenic Mice. Biochemical and Biophysical Research Communications. 289(2). 597–601. 5 indexed citations

20.

Nayernia, Karim, Detlef Böhm, Özlem Topaloglu, Gregor Schlüter, & Wolfgang Engel. (2001). Rat transition nuclear protein 2 regulatory region directs haploid expression of reporter gene in male germ cells of transgenic mice. Molecular Reproduction and Development. 58(4). 368–375. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact